The Global Nuclear Medicine Market is expected to grow from USD 6.8 billion in 2024 to USD 12.99 billion by 2032, with a projected CAGR of 9.30%. Key drivers include the rising prevalence of chronic diseases such as cancer and cardiovascular conditions, advancements in diagnostic imaging technologies, and the growing adoption of targeted radiopharmaceuticals. However, challenges such as high costs of equipment and radiopharmaceuticals, stringent regulatory approvals, and limited availability of medical isotopes may hamper growth. Major players in this market include Lantheus Medical Imaging, Cardinal Health, and GE Healthcare, among others. The report provides insights into industry trends, challenges, and future opportunities.
Wed, 20 Aug 2025 14:02:04 GMT | GlobeNewswire